Article Versions Notes

Luan X, Zhou H, Chen Y, Zhang X, Cui M, Chen K, Xu X, Zhang J, Xu B. A Preclinical Study of an ¹²⁵I-Labeled PSMA Ligand for Prostate-Cancer Puncture. Pharmaceuticals. 2022; 15(10):1252. https://doi.org/10.3390/ph15101252

Luan, Xiaohui, Haoxi Zhou, Yimin Chen, Xiaojun Zhang, Mengchao Cui, Kuang Chen, Xiaodan Xu, Jinming Zhang, and Baixuan Xu. 2022. "A Preclinical Study of an ¹²⁵I-Labeled PSMA Ligand for Prostate-Cancer Puncture" Pharmaceuticals 15, no. 10: 1252. https://doi.org/10.3390/ph15101252

Luan, X., Zhou, H., Chen, Y., Zhang, X., Cui, M., Chen, K., Xu, X., Zhang, J., & Xu, B. (2022). A Preclinical Study of an ¹²⁵I-Labeled PSMA Ligand for Prostate-Cancer Puncture. Pharmaceuticals, 15(10), 1252. https://doi.org/10.3390/ph15101252